Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Correction to: A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions.

Centeno CJ, Al-Sayegh H, Freeman MD, Smith J, Murrell WD, Bubnov R.

Int Orthop. 2018 Jan;42(1):223. doi: 10.1007/s00264-017-3680-2.

PMID:
29110069
2.

Treatment of lumbar degenerative disc disease-associated radicular pain with culture-expanded autologous mesenchymal stem cells: a pilot study on safety and efficacy.

Centeno C, Markle J, Dodson E, Stemper I, Williams CJ, Hyzy M, Ichim T, Freeman M.

J Transl Med. 2017 Sep 22;15(1):197. doi: 10.1186/s12967-017-1300-y.

3.

Performing a Better Bone Marrow Aspiration.

Friedlis MF, Centeno CJ.

Phys Med Rehabil Clin N Am. 2016 Nov;27(4):919-939. doi: 10.1016/j.pmr.2016.06.009. Review.

PMID:
27788908
4.
5.

A multi-center analysis of adverse events among two thousand, three hundred and seventy two adult patients undergoing adult autologous stem cell therapy for orthopaedic conditions.

Centeno CJ, Al-Sayegh H, Freeman MD, Smith J, Murrell WD, Bubnov R.

Int Orthop. 2016 Aug;40(8):1755-1765. doi: 10.1007/s00264-016-3162-y. Epub 2016 Mar 30. Erratum in: Int Orthop. 2018 Jan;42(1):223.

PMID:
27026621
6.

Anterior cruciate ligament tears treated with percutaneous injection of autologous bone marrow nucleated cells: a case series.

Centeno CJ, Pitts J, Al-Sayegh H, Freeman MD.

J Pain Res. 2015 Jul 31;8:437-47. doi: 10.2147/JPR.S86244. eCollection 2015.

7.

A prospective multi-site registry study of a specific protocol of autologous bone marrow concentrate for the treatment of shoulder rotator cuff tears and osteoarthritis.

Centeno CJ, Al-Sayegh H, Bashir J, Goodyear S, Freeman MD.

J Pain Res. 2015 Jun 5;8:269-76. doi: 10.2147/JPR.S80872. eCollection 2015.

8.

Safety and regulatory issues regarding stem cell therapies: one clinic's perspective.

Centeno CJ, Bashir J.

PM R. 2015 Apr;7(4 Suppl):S4-7. doi: 10.1016/j.pmrj.2014.12.013. Review.

PMID:
25864659
9.

Clinical challenges and opportunities of mesenchymal stem cells in musculoskeletal medicine.

Centeno CJ.

PM R. 2014 Jan;6(1):70-7. doi: 10.1016/j.pmrj.2013.08.612. Review.

PMID:
24439149
10.

Amide-type local anesthetics and human mesenchymal stem cells: clinical implications for stem cell therapy.

Dregalla RC, Lyons NF, Reischling PD, Centeno CJ.

Stem Cells Transl Med. 2014 Mar;3(3):365-74. doi: 10.5966/sctm.2013-0058. Epub 2014 Jan 16.

11.

Percutaneous injection of autologous, culture-expanded mesenchymal stem cells into carpometacarpal hand joints: a case series with an untreated comparison group.

Centeno CJ, Freeman MD.

Wien Med Wochenschr. 2014 Mar;164(5-6):83-7. doi: 10.1007/s10354-013-0222-4. Epub 2013 Aug 15.

PMID:
23949564
12.

Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique.

Centeno CJ, Schultz JR, Cheever M, Freeman M, Faulkner S, Robinson B, Hanson R.

Curr Stem Cell Res Ther. 2011 Dec;6(4):368-78.

PMID:
22023622
13.
14.

Safety and complications reporting on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique.

Centeno CJ, Schultz JR, Cheever M, Robinson B, Freeman M, Marasco W.

Curr Stem Cell Res Ther. 2010 Mar;5(1):81-93.

PMID:
19951252
15.

Regeneration of meniscus cartilage in a knee treated with percutaneously implanted autologous mesenchymal stem cells.

Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D.

Med Hypotheses. 2008 Dec;71(6):900-8. doi: 10.1016/j.mehy.2008.06.042. Epub 2008 Sep 10.

PMID:
18786777
16.

Increased knee cartilage volume in degenerative joint disease using percutaneously implanted, autologous mesenchymal stem cells.

Centeno CJ, Busse D, Kisiday J, Keohan C, Freeman M, Karli D.

Pain Physician. 2008 May-Jun;11(3):343-53.

17.

Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors.

Nieto Y, Aldaz A, Rifón J, Pérez-Calvo J, Zafra A, Zufia L, Viúdez A, Viteri S, Aramendía JM, Aristu J, Centeno C, Moreno M, Sayar O, Hernández M.

Biol Blood Marrow Transplant. 2007 Nov;13(11):1324-37. Epub 2007 Sep 7.

Supplemental Content

Loading ...
Support Center